
Expert Perspectives on the Latest Clinical Trial Updates in HR-Positive, HER2-Negative Early Breast Cancer
9/18/2025
0:00
32:07
More options, more questions. Get clarity on patient selection and optimizing adjuvant cyclin-dependent kinase cyclin-dependent kinase (CDK)4/6 inhibitor therapy.
Credit available for this activity expires: 9/16/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002908?ecd=bdc_podcast_libsyn_mscpedu
More episodes from "Keeping Current CME"
Don't miss an episode of “Keeping Current CME” and subscribe to it in the GetPodcast app.